| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |